Literature DB >> 9645315

Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection.

A Garcia1, H Johnson, D K Srivastava, D A Jayawardene, D R Wehr, R G Webster.   

Abstract

The control and eventual eradication of H5N2 influenza virus from domestic poultry in Mexico is dependent on the use of avian influenza (AI) vaccine strategies. This study was performed to determine the amount of hemagglutinin (HA) antigen required to control the signs of disease from a highly pathogenic H5N2 influenza virus (A/Chicken/ Queretaro/19/95) and the amount of antigen required to prevent shedding of virus from vaccinated birds. Six commercial inactivated water in oil H5N2 vaccines available in Mexico were compared with standardized vaccines to assess their efficacy. The amount of HA required to prevent the signs of disease from A/Chicken/Queretaro/19/95 influenza virus was approximately 0.4 microgram per dose. Each of the six commercially available vaccines prevented disease signs, and half of the vaccines significantly reduced viral shedding from vaccinated birds. There is a need for standardization of AI virus vaccine, and the antigen content should be increased in some of the commercially available AI vaccines in Mexico.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645315

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  6 in total

1.  Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

Authors:  Haroldo Toro; De-chu C Tang; David L Suarez; Matt J Sylte; Jennifer Pfeiffer; Kent R Van Kampen
Journal:  Vaccine       Date:  2006-09-25       Impact factor: 3.641

2.  Chronic wasting disease management in ranched elk using rectal biopsy testing.

Authors:  Nicholas J Haley; Davin M Henderson; Sarah Wycoff; Joanne Tennant; Edward A Hoover; Dan Love; Ed Kline; Aaron Lehmkuhl; Bruce Thomsen
Journal:  Prion       Date:  2018-02-22       Impact factor: 3.931

3.  A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.

Authors:  X Lu; T M Tumpey; T Morken; S R Zaki; N J Cox; J M Katz
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus.

Authors:  Terrence M Tumpey; Rene Alvarez; David E Swayne; David L Suarez
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

5.  Phylogenetic analysis, molecular changes, and adaptation to chickens of Mexican lineage H5N2 low-pathogenic avian influenza viruses from 1994 to 2019.

Authors:  Sungsu Youk; Christina M Leyson; Darren J Parris; Henry M Kariithi; David L Suarez; Mary J Pantin-Jackwood
Journal:  Transbound Emerg Dis       Date:  2022-03-04       Impact factor: 4.521

6.  Protection and virus shedding of falcons vaccinated against highly pathogenic avian influenza A virus (H5N1).

Authors:  Michael Lierz; Hafez M Hafez; Robert Klopfleisch; Dörte Lüschow; Christine Prusas; Jens P Teifke; Miriam Rudolf; Christian Grund; Donata Kalthoff; Thomas Mettenleiter; Martin Beer; Timm Hardert
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.